Cargando…
Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union
BACKGROUND: Although no authorization is available for antibiotics to treat bee diseases, some veterinary compounds are used by beekeepers, and each country sets its own thresholds. Inappropriate and excessive use of these drugs can cause allergic reactions and antibiotic resistance in humans who co...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brieflands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024329/ https://www.ncbi.nlm.nih.gov/pubmed/36942071 http://dx.doi.org/10.5812/ijpr-129432 |
_version_ | 1784909079611703296 |
---|---|
author | Yazdanpanah, Hassan Osouli, Mahraz Salamzadeh, Jamshid Karimi, Zakieh Rashidi, Elham Borhan, Ali Yazdanpanah, Alireza Eslamizad, Samira |
author_facet | Yazdanpanah, Hassan Osouli, Mahraz Salamzadeh, Jamshid Karimi, Zakieh Rashidi, Elham Borhan, Ali Yazdanpanah, Alireza Eslamizad, Samira |
author_sort | Yazdanpanah, Hassan |
collection | PubMed |
description | BACKGROUND: Although no authorization is available for antibiotics to treat bee diseases, some veterinary compounds are used by beekeepers, and each country sets its own thresholds. Inappropriate and excessive use of these drugs can cause allergic reactions and antibiotic resistance in humans who consume the remaining antibiotic residues in honey and its products. It is, therefore, relevant to monitor the presence of antibiotic residues in this matrix. OBJECTIVES: A rapid method for the simultaneous screening of nitrofuran metabolite residues in honey was validated according to Commission Decision 2002/657/EC (C.D 657) and the European guideline for the validation of screening methods for veterinary medicines. METHODS: This multi-analytical screening method enables the simultaneous determination of four nitrofuran metabolites [3-amino-2-oxazolidone (AOZ), 3-amino-5-morpholinomethyl-2-oxazolidinone (AMOZ), 1-Aminohydantoin HCl (ADH), and semicarbazide (SEC)] from a single honey sample. Thirty-five honey samples were collected randomly as real samples for screening from Tehran, IR Iran, Germany, and the Netherlands in 2018. RESULTS: For all four antibiotic residues, the positivity threshold T was higher than the cut-off value Fm, and no false-positive results were obtained for three antibiotics (AOZ, AMOZ, and SEC). Detection capabilities (CCβ) of all compounds were under the minimum required performance limit (MRPL) authorized by the European Commission (currently 1 μg/kg). The screening results of 15 domestic and 20 imported honey samples showed that the levels of AOZ in 6.66% and 10% of the samples, the level of AMOZ in 13.33% and 0% of the samples, and the level of SEC in 33.33% and 40% of the samples were less than the cut-off ([in relative light units (RLUs)], respectively. CONCLUSIONS: This study found that this technique is valid for detecting and quantifying three antibiotic residues in honey samples at the measured validation levels. This method was simple, rapid, and capable of simultaneously screening three nitrofuran metabolites from a single honey sample. |
format | Online Article Text |
id | pubmed-10024329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Brieflands |
record_format | MEDLINE/PubMed |
spelling | pubmed-100243292023-03-19 Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union Yazdanpanah, Hassan Osouli, Mahraz Salamzadeh, Jamshid Karimi, Zakieh Rashidi, Elham Borhan, Ali Yazdanpanah, Alireza Eslamizad, Samira Iran J Pharm Res Research Article BACKGROUND: Although no authorization is available for antibiotics to treat bee diseases, some veterinary compounds are used by beekeepers, and each country sets its own thresholds. Inappropriate and excessive use of these drugs can cause allergic reactions and antibiotic resistance in humans who consume the remaining antibiotic residues in honey and its products. It is, therefore, relevant to monitor the presence of antibiotic residues in this matrix. OBJECTIVES: A rapid method for the simultaneous screening of nitrofuran metabolite residues in honey was validated according to Commission Decision 2002/657/EC (C.D 657) and the European guideline for the validation of screening methods for veterinary medicines. METHODS: This multi-analytical screening method enables the simultaneous determination of four nitrofuran metabolites [3-amino-2-oxazolidone (AOZ), 3-amino-5-morpholinomethyl-2-oxazolidinone (AMOZ), 1-Aminohydantoin HCl (ADH), and semicarbazide (SEC)] from a single honey sample. Thirty-five honey samples were collected randomly as real samples for screening from Tehran, IR Iran, Germany, and the Netherlands in 2018. RESULTS: For all four antibiotic residues, the positivity threshold T was higher than the cut-off value Fm, and no false-positive results were obtained for three antibiotics (AOZ, AMOZ, and SEC). Detection capabilities (CCβ) of all compounds were under the minimum required performance limit (MRPL) authorized by the European Commission (currently 1 μg/kg). The screening results of 15 domestic and 20 imported honey samples showed that the levels of AOZ in 6.66% and 10% of the samples, the level of AMOZ in 13.33% and 0% of the samples, and the level of SEC in 33.33% and 40% of the samples were less than the cut-off ([in relative light units (RLUs)], respectively. CONCLUSIONS: This study found that this technique is valid for detecting and quantifying three antibiotic residues in honey samples at the measured validation levels. This method was simple, rapid, and capable of simultaneously screening three nitrofuran metabolites from a single honey sample. Brieflands 2022-11-22 /pmc/articles/PMC10024329/ /pubmed/36942071 http://dx.doi.org/10.5812/ijpr-129432 Text en Copyright © 2022, Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Research Article Yazdanpanah, Hassan Osouli, Mahraz Salamzadeh, Jamshid Karimi, Zakieh Rashidi, Elham Borhan, Ali Yazdanpanah, Alireza Eslamizad, Samira Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union |
title | Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union |
title_full | Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union |
title_fullStr | Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union |
title_full_unstemmed | Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union |
title_short | Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union |
title_sort | simultaneous screening of nitrofuran metabolites in honey using biochip array technology: validation study according to the decision 2002/657/ec of the european union |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024329/ https://www.ncbi.nlm.nih.gov/pubmed/36942071 http://dx.doi.org/10.5812/ijpr-129432 |
work_keys_str_mv | AT yazdanpanahhassan simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion AT osoulimahraz simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion AT salamzadehjamshid simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion AT karimizakieh simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion AT rashidielham simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion AT borhanali simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion AT yazdanpanahalireza simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion AT eslamizadsamira simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion |